Answers are grounded in this paper and cite their sources.
Near-infrared (NIR)-emissive carbon dots (NIR-CDs) have emerged as a distinctive class of ultrasmall carbon nanomaterials for biomedical imaging because their optical absorption/emission can be shifted from the visible region toward the NIR-I (~700–1000 nm) and NIR-II (~1000–1700 nm) biological windows while retaining the characteristic aqueous dispersibility, photostability, surface functionality, and favorable biocompatibility. However, it is challenging to establish a reproducible structure–composition–excited-state relationship that simultaneously provides long-wavelength excitation, high quantum yield (QY), narrow emission, photostability, appropriate pharmacokinetics, and sufficient optical absorption for multimodal imaging. This review critically examines the strategic engineering of NIR-CDs from molecular precursor chemistry to carbonized cores, surface states/defects, heteroatom/metal doping, molecular engineering, and supramolecular self-assembly. The review further examines NIR fluorescence (NIR-FL), multiphoton, afterglow phosphorescence, photoacoustic (PA), magnetic resonance (MR), and multimodal imaging. Finally, the remaining challenges such as NIR-II QY, structural heterogeneity, reproducibility, ambiguity in intrinsic/molecular fluorescence, biosafety, and insufficient clinical validation were discussed together with future prospects.
No takes yet. Share an insight, caveat, or question.
Moniruzzaman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: